These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9491349)
1. The discovery of indicator variables for QSAR using inductive logic programming. King RD; Srinivasan A J Comput Aided Mol Des; 1997 Nov; 11(6):571-80. PubMed ID: 9491349 [TBL] [Abstract][Full Text] [Related]
2. New approach to pharmacophore mapping and QSAR analysis using inductive logic programming. Application to thermolysin inhibitors and glycogen phosphorylase B inhibitors. Marchand-Geneste N; Watson KA; Alsberg BK; King RD J Med Chem; 2002 Jan; 45(2):399-409. PubMed ID: 11784144 [TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationships by neural networks and inductive logic programming. II. The inhibition of dihydrofolate reductase by triazines. Hirst JD; King RD; Sternberg MJ J Comput Aided Mol Des; 1994 Aug; 8(4):421-32. PubMed ID: 7815093 [TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationships by neural networks and inductive logic programming. I. The inhibition of dihydrofolate reductase by pyrimidines. Hirst JD; King RD; Sternberg MJ J Comput Aided Mol Des; 1994 Aug; 8(4):405-20. PubMed ID: 7815092 [TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships derived by machine learning: the use of atoms and their bond connectivities to predict mutagenicity by inductive logic programming. King RD; Muggleton SH; Srinivasan A; Sternberg MJ Proc Natl Acad Sci U S A; 1996 Jan; 93(1):438-42. PubMed ID: 8552655 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR Study on dihydro-1,3,5-triazines and their spiro derivatives as DHFR inhibitors by comparative molecular field analysis (CoMFA). Ma X; Xiang G; Yap CW; Chui WK Bioorg Med Chem Lett; 2012 May; 22(9):3194-7. PubMed ID: 22483391 [TBL] [Abstract][Full Text] [Related]
9. Scaffold hopping in drug discovery using inductive logic programming. Tsunoyama K; Amini A; Sternberg MJ; Muggleton SH J Chem Inf Model; 2008 May; 48(5):949-57. PubMed ID: 18457387 [TBL] [Abstract][Full Text] [Related]
10. A general approach for developing system-specific functions to score protein-ligand docked complexes using support vector inductive logic programming. Amini A; Shrimpton PJ; Muggleton SH; Sternberg MJ Proteins; 2007 Dec; 69(4):823-31. PubMed ID: 17910057 [TBL] [Abstract][Full Text] [Related]
11. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function. Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013 [TBL] [Abstract][Full Text] [Related]
12. Discovering H-bonding rules in crystals with inductive logic programming. Ando HY; Dehaspe L; Luyten W; Van Craenenbroeck E; Vandecasteele H; Van Meervelt L Mol Pharm; 2006; 3(6):665-74. PubMed ID: 17140254 [TBL] [Abstract][Full Text] [Related]
13. Adaptive neuro-fuzzy inference system: an instant and architecture-free predictor for improved QSAR studies. Loukas YL J Med Chem; 2001 Aug; 44(17):2772-83. PubMed ID: 11495588 [TBL] [Abstract][Full Text] [Related]
14. Quantitative structure-activity relationships by evolved neural networks for the inhibition of dihydrofolate reductase by pyrimidines. Landavazo DG; Fogel GB; Fogel DB Biosystems; 2002 Feb; 65(1):37-47. PubMed ID: 11888662 [TBL] [Abstract][Full Text] [Related]
15. Beware of External Validation! - A Comparative Study of Several Validation Techniques used in QSAR Modelling. Majumdar S; Basak SC Curr Comput Aided Drug Des; 2018; 14(4):284-291. PubMed ID: 29701159 [TBL] [Abstract][Full Text] [Related]
16. Effects of variable selection on CoMFA coefficient contour maps in a set of triazines inhibiting DHFR. Greco G; Novellino E; Pellecchia M; Silipo C; Vittoria A J Comput Aided Mol Des; 1994 Apr; 8(2):97-112. PubMed ID: 8064336 [TBL] [Abstract][Full Text] [Related]
17. Application of molecular docking and PSO-SVR intelligent approaches in antimalarial activity prediction of enantiomeric cycloguanil analogues. Inthajak K; Toochinda P; Lawtrakul L SAR QSAR Environ Res; 2018 Dec; 29(12):957-974. PubMed ID: 30381963 [TBL] [Abstract][Full Text] [Related]
18. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase. Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921 [TBL] [Abstract][Full Text] [Related]
19. PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. Dixon SL; Smondyrev AM; Knoll EH; Rao SN; Shaw DE; Friesner RA J Comput Aided Mol Des; 2006; 20(10-11):647-71. PubMed ID: 17124629 [TBL] [Abstract][Full Text] [Related]
20. Boosting support vector regression in QSAR studies of bioactivities of chemical compounds. Zhou YP; Jiang JH; Lin WQ; Zou HY; Wu HL; Shen GL; Yu RQ Eur J Pharm Sci; 2006 Jul; 28(4):344-53. PubMed ID: 16697155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]